Reference is further made to stock exchange announcement of yesterday regarding the successful private placement of new shares in the company for gross proceeds of approximately NOK 297,644,400, ...

All patients in the treatment arm remain disease-free after a minimum of 2-year follow-up in the randomized Phase I trial in resected HPV-negative locally advanced head and neck cancer – Demonstrating ...

semisubmersible drilling rigs, capable of working worldwide. This announcement is not an offer for sale of securities in the United States. The securities referred to in this announcement have not ...

For more information, please visit www.cadeler.com. To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.

acquired a total of 18,007 shares in Moreld. Of these, 953 shares were acquired at a price of NOK 13.20 per share, and 17,054 shares were acquired at a price of NOK 13.26 per share. Following these ...

“When people are diagnosed with metastatic pancreatic adenocarcinoma, the most important question remains: how long will they have with their loved ones,” said Dr. Vincent Chung, Medical Oncologist, ...

attached notification on the dates set out therein. Please see the attached file for further details.

arrangements to purchase such securities. The Financial Supervisory Authority of Norway has approved the Offer Document. To subscribe to Press releases from this issuer, visit the Subscription to ...

Aker Solutions will book the award as order intake in the second quarter of 2025 in the Renewables and Field Development segment. [1]Aker Solutions defines a 'significant' contract as being between ...

(ii) Ratified the appointment of Deloitte Certified Public Accountants S.A. as independent auditors for the year ending December 31, 2025. Following the Annual Meeting, the Board of Directors of the ...

expected and the new target implementation date is end of June 2025. The Company has for this purpose obtained a formal extension of the waiver from the senior secured lender and working capital ...

to USD 10.1 million in Q1 2024. * EBITDA Improvement: EBITDA of USD 4.9 million for the first quarter, a significant improvement from an EBITDA loss of USD 17.0 million in Q1 2024. * Net Earnings: Net ...